Did Incyte (INCY) report any disagreement related to Susanne Schaffert’s resignation?

Incyte stated that Susanne Schaffert’s resignation was not the result of any disagreement with the company. This includes no disagreement about its operations, policies, or practices, suggesting the resignation was not tied to a dispute.

Incyte (INCY) Board member Susanne Schaffert to step down April 15, 2026

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Incyte Corporation reported that Board member Susanne Schaffert has resigned from its Board of Directors. She notified the company on March 26, 2026, and her resignation will be effective April 15, 2026.

The company stated that her resignation was not due to any disagreement regarding its operations, policies, or practices, and the Board expressed appreciation for her service since 2022.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Notification date: March 26, 2026 Effective resignation date: April 15, 2026 Board service start year: 2022

3 metrics

Notification date March 26, 2026 Date Dr. Schaffert notified Incyte of her resignation

Effective resignation date April 15, 2026 Date her resignation from the Board becomes effective

Board service start year 2022 Year Dr. Schaffert joined Incyte’s Board of Directors

Key Terms

Board of Directors, Item 5.02, Emerging growth company, Securities Exchange Act of 1934

4 terms

Board of Directors financial

"she was resigning from the Company’s Board of Directors (the “Board”)"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

Item 5.02 regulatory

"Item 5.02 Departure of Directors or Certain Officers; Election of Directors"

Emerging growth company regulatory

"Emerging growth company o Item 5.02"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Securities Exchange Act of 1934 regulatory

"pursuant to the requirements of the Securities Exchange Act of 1934"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

03/30/2026 - 05:35 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 26, 2026

INCYTE CORPORATION

(Exact name of registrant as specified in its charter)


Delaware	001-12400	94-3136539
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)


1801 Augustine Cut-Off Wilmington, DE			19803
(Address of principal executive offices)			(Zip Code)

(302) 498-6700

(Registrant’s telephone number,

including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of exchange on which registered
Common Stock, $.001 par value per share	INCY	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b—2 of the Securities Exchange Act of 1934 (§ 240.12b—2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 26, 2026, Susanne Schaffert notified Incyte Corporation (the “Company”) that she was resigning from the Company’s Board of Directors (the “Board”), effective as of April 15, 2026. The resignation of Dr. Schaffert, who has been a member of the Company’s Board since 2022, was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Board thanks Dr. Schaffert for her thoughtful counsel and meaningful contributions to the Company during her service.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 30, 2026
	INCYTE CORPORATION

	By:	/s/ Richard Hoffman
		Richard Hoffman
		Executive Vice President and General Counsel

Source: View Original Filing on SEC EDGAR

FAQ

Why did Susanne Schaffert resign from Incyte (INCY)’s Board of Directors?

Susanne Schaffert resigned from Incyte’s Board of Directors effective April 15, 2026. The company stated her resignation was not due to any disagreement regarding its operations, policies, or practices, indicating an amicable departure from the Board.

When is Susanne Schaffert’s resignation from Incyte (INCY) effective?

Her resignation from Incyte’s Board of Directors is effective April 15, 2026. She notified the company on March 26, 2026, providing several weeks’ notice before her departure from the Board becomes effective.

How long did Susanne Schaffert serve on Incyte (INCY)’s Board?

Susanne Schaffert has been a member of Incyte’s Board of Directors since 2022. Her service will end on April 15, 2026, when her resignation becomes effective, following several years of Board involvement and contributions.

What did Incyte (INCY)’s Board say about Susanne Schaffert’s service?

Incyte’s Board expressed thanks to Susanne Schaffert for her thoughtful counsel and meaningful contributions. The acknowledgment highlights appreciation for her work and support during her tenure on the Board since 2022.

Filing Exhibits & Attachments

3 documents